We are live on ! Find out more
AKTX

Akari Therapeutics
AKTX

15 hedge funds and large institutions have $4.19M invested in Akari Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

7% more funds holding

Funds holding: 14 → 15 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

34% less capital invested

Capital invested by funds: $6.37M → $4.19M (-$2.18M)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
3
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$9.1K
2
Citadel Advisors
Citadel Advisors
Florida
+$7.86K
3
Renaissance Technologies
Renaissance Technologies
New York
+$7.86K
4
TSS
Two Sigma Securities
New York
+$7.03K
5
LPL Financial
LPL Financial
California
+$5.79K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$424K
2
SM
Sabby Management
Florida
-$225K
3
HTC
Haverford Trust Company
Pennsylvania
-$13K
4
TC
Truvestments Capital
Florida
-$414
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.72M -$225K -544 -11%
AC
2
Armistice Capital
New York
$1.63M -$424K -1,025 -19%
OFW
3
Omnia Family Wealth
Florida
$368K – – –
NMC
4
NEA Management Company
Maryland
$212K – – –
LPL Financial
5
LPL Financial
California
$63.2K +$5.79K +14 +9%
HP
6
Hikari Power
Japan
$61K – – –
BMCM
7
Bryn Mawr Capital Management
Pennsylvania
$47K – – –
Millennium Management
8
Millennium Management
New York
$27K +$9.1K +22 +47%
Renaissance Technologies
9
Renaissance Technologies
New York
$26K +$7.86K +19 +38%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$14K – – –
Citadel Advisors
11
Citadel Advisors
Florida
$7.57K +$7.86K +19 New
TSS
12
Two Sigma Securities
New York
$6.31K +$7.03K +17 New
VF
13
Virtu Financial
New York
$5K +$5.38K +13 New
Bank of America
14
Bank of America
North Carolina
$1.41K – – –
TC
15
Truvestments Capital
Florida
$472 -$414 -1 -50%
HTC
16
Haverford Trust Company
Pennsylvania
– -$13K -25 Closed

AKTX Hedge Fund Activity: Q4 2022 in Review

15 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q4 2022, worth a combined $4.19M — down 34% from $6.37M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AKTX positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Millennium Management, adding an estimated $9.1K. The largest seller was Armistice Capital, cutting an estimated $424K.

  • 15 institutional investors held Akari Therapeutics (AKTX) as of Q4 2022, up from 14 in Q3 2022.
  • Funds reported $4.19M of Akari Therapeutics stock for Q4 2022, down 34% quarter-over-quarter.
  • 3 funds opened new Akari Therapeutics positions in Q4 2022 and 2 closed out, a net change of +1 holder.
  • The largest Akari Therapeutics buyer in Q4 2022 was Millennium Management, an estimated $9.1K added.
  • The largest Akari Therapeutics seller in Q4 2022 was Armistice Capital, an estimated $424K sold.

Based on aggregated 13F filings for Q4 2022.